# Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDS

> **NCT04402359** · — · COMPLETED · sponsor: **King Abdul Aziz Specialist Hospital** · enrollment: 200 (actual)

## Conditions studied

- Ventilator Associated Pneumonia

## Interventions

- **DRUG:** meropenem
- **DRUG:** ceftazidime 2 grams and avibactam 500
- **DEVICE:** ventilator

## Key facts

- **NCT ID:** NCT04402359
- **Lead sponsor:** King Abdul Aziz Specialist Hospital
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-05
- **Primary completion:** 2019-12-28
- **Final completion:** 2019-12-30
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04402359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04402359, "Usage of Meropenem/Gentamicin Versus Ceftazidime/Avibactam in ARDS". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT04402359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*